Company / CapEx per Share
Corcept Therapeutics Incorporated CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2025
5-year range
$0.00 / $0.02
FY2021-FY2025
Trend
-90.4%
vs FY2024
Sector context
#163 of 192
Health Care
What the data says
Corcept Therapeutics Incorporated's capex per share of $0.00 is lower than 85% of companies in the Health Care sector (FY2025). CapEx per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2023 to $0.02 in FY2024.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of -5.1%.
Improved from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -44.4%
- 5-Year CAGR
- -5.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 192This company $0.00 Sector average $2.46
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 90.4% year-over-year.
- Ranks #163 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2024.
- Lowest capex per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -90.4% |
| FY2024 | $0.02 | +1529.5% |
| FY2023 | $0.00 | -89.0% |
| FY2022 | $0.01 | +25.4% |
| FY2021 | $0.01 | +258.3% |
| FY2020 | $0.00 | -28.6% |
| FY2019 | $0.00 | +115.4% |
| FY2018 | $0.00 | -54.5% |
| FY2017 | $0.00 | +134.2% |
| FY2016 | $0.00 | +846.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026